BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Choi ST, Ahn SV, Lee PH, Moon CM. The cancer risk according to three subtypes of ANCA-associated vasculitis: A propensity score-matched analysis of a nationwide study. Semin Arthritis Rheum 2021;51:692-9. [PMID: 34139522 DOI: 10.1016/j.semarthrit.2021.03.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao R, Wu Z, Xu X, Pu J, Pan S, Zhang Y, Zhuang S, Yang L, Liang Y, Song J, Tang J, Wang X. Predictors of poor prognosis in ANCA-associated vasculitis (AAV): a single-center prospective study of inpatients in China. Clin Exp Med. [DOI: 10.1007/s10238-022-00915-z] [Reference Citation Analysis]
2 Austin K, Janagan S, Wells M, Crawshaw H, Mcadoo S, Robson JC. ANCA Associated Vasculitis Subtypes: Recent Insights and Future Perspectives. JIR 2022;Volume 15:2567-82. [DOI: 10.2147/jir.s284768] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Tieu J, Lester S, Raymond W, Keen H, Hill CL, Nossent J. Cancer in Anti-Neutrophil Cytoplasm Antibody-Associated Vasculitis and Polyarteritis Nodosa in Australia: A Population-Based Study. ACR Open Rheumatol 2021. [PMID: 34877820 DOI: 10.1002/acr2.11378] [Reference Citation Analysis]
4 Treppo E, Binutti M, Agarinis R, De Vita S, Quartuccio L. Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives. J Clin Med 2021;10:3773. [PMID: 34501224 DOI: 10.3390/jcm10173773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]